MAPT and Alzheimer disease: Given that tau hyperphosphorylation is a hallmark of several neurological disorders, including Alzheimer’s disease (AD) and traumatic brain injury (TBI), the authors tested whether they could link TBI-induced calpain-2 activation, via PTPN13 cleavage, to tau hyperphosphorylation.